BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 21, 2007
View Archived Issues
Chugai reports domestic and overseas developments for 2006
Read More
Novel metabolic drugs described in recent patent literature
Read More
Alitretinoin demonstrates efficacy in chronic hand dermatitis
Read More
Phase III results demonstrate efficacy of M6G in patients with postoperative pain
Read More
Vernakalant (i.v.) NDA accepted for review
Read More
Preclinical studies show CF-102 active against hepatitis B virus
Read More
BTG inlicenses opioid agonist for postoperative pain
Read More
Roche grants GSK rights to non-prescription orlistat
Read More
ElSohly Laboratories licenses GelSite technology to formulate anticancer drug
Read More
University of Texas researchers study chlamydial prevention vaccine
Read More
Metabolic to announce phase IIb results for AOD-9604
Read More
Tripep partners with Kringle on ChronSeal
Read More
Entelos and Organon extend rheumatoid arthritis collaboration
Read More
Ecopia BioSciences and Caprion advance merger plans
Read More
ICX-SKN skin graft substitute studied in phase I trial
Read More
CAM-2028 cleared to begin phase II oral mucositis study
Read More
Xanthine oxidoreductase: a novel target for obesity and metabolic diseases
Read More
Telavancin NDA accepted for review
Read More
Bone regeneration seen with tissue repair cells
Read More
GVAX cancer vaccine safe after stem cell transplant in acute myeloid leukemia patients
Read More
Results with Favld immunotherapy promising in non-Hodgkin's lymphoma
Read More
ZIO-101 well tolerated in phase I study in multiple myeloma
Read More
Heat shock protein 90 inhibitor shows promise for Alzheimer's disease in preclinical studies
Read More
Novel agents for cardiovascular disorders disclosed in Vertex and Merck Frosst patents
Read More
AMR and Bristol-Myers Squibb patent discloses new agents for ADHD
Read More